Merck’s pill to treat rare type of tumour gets approval from US regulator
HQ Team May 15, 2025: Merck & Co. got approval from the US Food and Drug Administration for a pill to treat a.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team May 15, 2025: Merck & Co. got approval from the US Food and Drug Administration for a pill to treat a.
HQ Team November 22, 2023: Tumour molecules can rob the human body’s immune cells to deprive them of their energy to fuel the.
Glenmark Specialty SA, a subsidiary of India’s Glenmark Pharmaceuticals, has got investigational new drug clearance from the FDA to conduct clinical trials in.